Science that

REVOLUTIONIZES

Using key discoveries in the field of liver health, we’re innovating treatment for progressive non-viral liver diseases, solving some of today’s toughest medical challenges and building healthier tomorrows.

FARNESOID X RECEPTOR

Research is shedding light on the complex and powerful connection between bile acid and the farnesoid X receptor (FXR). Understand the metabolic effects of FXR.

Clinical
Trials

We are conducting and currently recruiting for several clinical trials.

OUR PIPELINE

Intercept is expanding its pipeline to feature new indications for liver diseases with limited therapeutic options. Take a look at the direction we are going.

Learn more

DISCOVERY COMPOUNDS

Intercept is focused on developing our lead compound, obeticholic acid, but we are also looking into the future with 2 novel compounds.

Learn more

MEDICAL INFORMATION REQUEST FORM

If you are a healthcare professional and have a medical inquiry, submit your request.

LEARN MORE

INVESTIGATOR INITIATED RESEARCH

We support independent, unsolicited research related to progressive non-viral liver diseases. Submit a proposal for consideration.

Learn more

SCIENTIFIC PRESENTATIONS

View scientific presentations for detailed clinical information about Intercept's proprietary bile acid chemistry.

Learn more

PARTNERING

We are evaluating out-licensing opportunities for a preclinical product candidate.

Learn more